top of page
This website was created by Done Wright Media

Clinical Trials

Sickle Cell Disease Trials

Agios Pharmaceuticals, Inc.; Active Not Recruiting

A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP);

NCT05031780

CSL Behring; Phase 2; Recruiting

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

NCT07224360

Agios Pharmaceuticals, Inc. Phase 3; Recruiting

A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (REIGNITE)

NCT07656415

Sanofi; Phase 3; Recruiting

The Efficacy and Safety of Rilzabrutinib in Patients Aged 10 to 65 Years With Sickle-cell Disease (LIBRA)

NCT06975865

Novartis Pharmaceuticals; Phase 3; Recruiting

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/​kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

NCT06439082

Pfizer; Phase 2/3; Recruiting

A Phase 2/3 Randomized, Multicenter Study of Osivelotor Administered Orally to Adult and Adolescent Participants with Sickle Cell Disease (DREAM)

NCT05431088

Hemophilia Trials

Sanofi; Phase 4; Recruiting

An open-label, single-arm treatment study to investigate the safety and tolerability of switching from emicizumab to fitusiran prophylaxis in male participants aged ≥12 years of age with severe hemophilia A, with, or without inhibitors (SWITCH)

NCT06145373

Clinics We Are Working With

southern specialty health clinic

Southern Specialty Clinic

Specializing in Hematology and Metabolic Medicine.

mississippi asthma and allergy clinic

Mississippi Asthma & Allergy Clinic

Specializing in Asthma, Allergy and Immunology.

An Ever Expanding List!

We continue to expand our network through ongoing partnerships with clinics and healthcare providers who share our commitment to advancing clinical research and patient care.

bottom of page